ARCHIVES

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

This article is from The Cancer Letter archive.

Vol. 16 No. 34 | September 7, 1990

Download PDF Visit The Full Archive

Related Articles

ACS Research Grants Hit $78.2 Million

July 18, 1986

Tobacco Council Announces 12 New Awards, Six Relating To Smoking

August 2, 1974

DeVita Suggest Chop Should Be Expanded, Given Long Term Status, But Only With A “Quid Pro Quo”

March 20, 1981

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

In Brief: David Chambers named deputy director for implementation science at NCI DCCPS

December 5, 2014

Rauscher For Cancer Program

May 20, 1977